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The Validity, Reliability, Measurement Error, and Minimum 
Detectable Change of the 30-Second Fast-Paced Walk Test 
in Persons with Knee Osteoarthritis: A Novel Test of  
Short-Distance Walking Ability
Lisa T. Hoglund,1  Eric Folkins,2 Laura Pontiggia,2 and Michael W. Knapp2
Objective. To develop and establish the reliability, validity, measurement error, and minimum detectable change 
of a novel 30‐second fast‐paced walk test (30SFW) in persons with knee osteoarthritis (OA) that is easy to administer 
and can quantify walking performance in persons of all abilities.
Methods. Twenty females with symptomatic knee OA (mean age [SD] 58.30 [8.05] years) and 20 age‐ and sex‐
matched asymptomatic controls (57.25 [8.71] years) participated in the study. Participants completed questionnaires 
of demographic and clinical data, the Knee Injury and Osteoarthritis Outcome Score (KOOS), and the 36‐item Short 
Form Health Survey (SF‐36) followed by 30SFW performance. Participants returned 2‐7 days later and performed the 
30SFW again.
Results. The knee OA group reported function that was worse than controls (all KOOS subscales; P < 0.0001). 
The 30SFW intrarater and interrater reliability were excellent [ICC(2,1) = 0.95‐0.99]. Knee OA participants walked a 
shorter distance in the 30SFW than controls (mean [SD]: OA 44.4 m [9.5 m]; control 58.1 m [7.8 m]; P < 0.0001). 
Positive strong correlations were found between the 30SFW and the KOOS–Activity of Daily Living, SF‐36‐Physical 
Functioning, and SF‐36‐Physical Health Composite scores (P < 0.0001). A nonsignificant, weak correlation between 
30SFW and SF‐36‐Mental Health scores was present (r = 0.32, P = 0.05).
Conclusion. The 30SFW has excellent intrarater and interrater reliability. The 30SFW demonstrated excellent 
known groups, convergent, and discriminant validity as a measure of short‐distance walking ability in persons with 
knee OA. Clinicians and researchers should consider using the 30SFW to quantify walking ability in persons with knee 
OA and assess walking ability change.
INTRODUCTION
Knee osteoarthritis (OA) is a growing public health problem 
and a leading contributor to disability worldwide (1). Approximately 
14 million adults in the United States have symptomatic knee OA, 
which is a cause of pain, reduced walking ability, and participa-
tion restriction (2,3). The presence of symptomatic knee or hip 
OA was the strongest contributor to self‐reported walking difficulty 
of all chronic health conditions in adults 55 years or younger (4). 
Reduced walking ability is proposed to cause reduced physical 
activity, which is a risk factor for death that is due to cardiovascular 
disease (5–7).
Because reduced walking ability may result in disability 
and early mortality, it is critical that health care providers and 
researchers have valid, reliable, and easily administered out-
come measures of walking ability. Although patient‐reported 
outcome measures for physical function are available, patient‐
reported results for walking ability are determined predominantly 
by pain intensity rather than physical walking performance (8,9). 
Measurement of actual walking ability with reliable, valid physical 
performance measures (PPMs) is critical to quantitatively assess 
walking ability in persons with knee OA. Currently, there is no 
PPM of walking ability that is reliable and valid in persons with 
knee OA across the spectrum of pain severity (10,11).
Current PPMs for short‐distance walking are based on time 
to walk a set distance and cannot be used by those unable to 
complete the required distance (floor effect) (12). Importantly, 
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current PPMs for walking distance are difficult to conduct in 
clinical settings because of the requirement for straight, unob-
structed walkways of 20 m or more in length (12). The Osteo-
arthritis Research Society International (OARSI) recommended 
that a PPM of short‐distance walking based on time be devel-
oped and validated for persons with knee OA (12). Such a PPM 
would be useful as a measure of an individual’s walking ability 
and to assess response to interventions. The objective of this 
study was to develop and establish the reliability, validity, meas-
urement error, and minimum detectable change (MDC) of a novel 
30‐second fast‐paced walk test (30SFW) for persons with knee 
OA that is easy to administer and can quantify walking perfor-
mance in persons of all abilities. We hypothesized that 1) the 
30SFW would demonstrate excellent intrarater (test‐retest) and 
interrater reliability evidenced by an intraclass correlation coef-
ficient (ICC) that is 0.91 or greater; 2) that the 30SFW would 
demonstrate convergent construct validity evidenced by strong 
correlations (r ≥ 0.60) between 30SFW scores and patient‐
reported physical function scores; 3) that the 30SFW would 
demonstrate discriminant construct validity evidenced by weak 
correlations (r ≤ 0.39) between 30SFW and a patient‐reported 
mental health score; and 4) that the 30SFW would demonstrate 
known groups construct validity evidenced by a significant differ-
ence (P < 0.05) in scores on the 30SFW between knee OA and 
asymptomatic control groups (13).
METHODS
Participants. Twenty participants with symptomatic knee 
OA and 20 age‐ and sex‐matched asymptomatic control sub-
jects participated in the study. An a priori power analysis based 
on ICC2,1 for intrarater and interrater reliability indicated that a 
minimum of 16 participants were required in order to achieve an 
optimal ICC of 0.91 and a minimally acceptable level of reliability 
of 0.70 at the 0.05 significance level and power of 0.80. For the 
validity analysis, a minimum of 15 participants were required in 
order to achieve a Pearson correlation coefficient of 0.85 and a 
minimally acceptable correlation of 0.5 at a significance level of 
0.05 and power 0.80. In order to account for potential dropouts, 
20 participants with knee OA and 20 asymptomatic control par-
ticipants were recruited (Table  1). Inclusion criteria for the knee 
OA group were as follows: age 40‐75 years, self‐reported physi-
cian’s diagnosis of knee OA, knee pain in one or both knees most 
days of the month for at least one month in the previous year, and 
the ability to walk without an assistive device. Inclusion criteria for 
the control group were as follows: age 40‐75 years, no physi-
cian‐diagnosed knee OA, no reported knee pain on most days 
of the month for 1 month in the previous year, and the ability to 
walk without an assistive device. Exclusion criteria for both groups 
included pregnancy, known OA of other lower‐extremity joints, 
history of lower‐extremity arthroplasty or osteotomy, other neuro-
musculoskeletal or systemic conditions that may cause knee pain 
or limit walking performance, knee injections within the previous 
30 days, and any medical or physical condition that would make 
walking quickly contraindicated. Participants were recruited from 
the Thomas Jefferson University (TJU) Hospital and Mercy Fitzger-
ald Hospital physical therapy clinics as well as through advertise-
ments at TJU and the University of the Sciences in Philadelphia. 
The study was approved by the Institutional Review Boards of the 
University of the Sciences, Mercy Fitzgerald Hospital, and TJU. 
The research was performed in accordance with the Declaration 
of Helsinki, and all participants signed a written informed consent 
prior to inclusion in the study.
Patient-reported outcome measures. Construct valid-
ity testing was performed by comparing 30SFW scores to partic-
ipant scores on three subscales of two patient‐reported outcome 
measures (PROMs). The Knee Injury and Osteoarthritis Outcome 
Score (KOOS) is a knee‐region–specific PROM for use with per-
sons with knee OA or injuries that may cause knee OA (meniscal 
or anterior cruciate ligament tears, etc) (14). The KOOS has five 
subscales, including the Activity of Daily Living (ADL) subscale 
(KOOS‐ADL); each subscale is scored out of 100, and higher 
scores indicate better status. The KOOS has been shown to be 
reliable and valid to assess health status in persons with knee OA 
(15).
The Rand Medical Outcomes Study 36‐item Short Form 
Health Survey (SF‐36) is a general quality‐of‐life PROM with eight 
subscales, including physical functioning (SF‐36‐PF) and mental 
health (SF‐36‐MH) subscales (16). A Physical Health Compos-
ite Summary score of the SF‐36 (SF‐36‐PHC) can be calculated 
using scores from four subscales (physical functioning, role limita-
tions due to physical health, bodily pain, and general health) (17). 
The SF‐36 has been shown to be reliable and valid as a measure 
SIGNIFICANCE & INNOVATIONS
• Symptomatic knee osteoarthritis (OA) is one of the 
strongest contributors to reduced walking ability, a 
cause of reduced physical activity, and participation 
restriction. Therefore, it is vital that clinicians and 
researchers have valid and reliable physical perfor-
mance measures (PPMs) of walking ability for per-
sons with knee OA that do not require large time or 
space requirements.
• This study shows that the 30-second fast-paced 
walk test (30SFW) is a reliable and valid measure 
of short-distance walking ability in persons with 
knee OA. The 30SFW is the first PPM to evaluate 
short-distance walking ability with evidence for 
both reliability and validity as well as minimum de-
tectable change.
• The 30SFW is feasible for use in clinical, research, 
and community settings to quantify walking ability 
for persons with knee OA. This PPM requires mini-
mal time, space, and special equipment.
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of quality of life and perceived function in persons with knee OA 
(18,19). Each subscale and composite summary score is scored 
out of 100, with higher scores indicating better status.
Study instrument and procedure. Six physical thera-
pists and one physical therapist assistant conducted all tests 
and were trained in the procedure by the principal investigator. 
After signing the written consent form, participants completed 
questionnaires of demographic and clinical data, the KOOS, and 
the SF‐36. Participants then performed the 30SFW test, in which 
examiners used a standardized script of verbal instructions. Par-
ticipants stood with the front of their shoes on a starting line and 
were instructed as follows: “Walk the farthest distance you can 
by walking at a fast, but safe, speed for 30 seconds. I will tell 
you when to begin and keep walking until I say ‘Stop.’ To tell 
you when to begin, I will count down from 3. Are you ready? 
3‐2‐1‐Go!” Participants performed one practice trial at a moder-
ate pace; two scored trials at a fast pace were performed with a 
5‐minute rest between scored trials. Participants rated any knee 
pain before and after each scored trial with a numeric pain rating 
(0‐10, 0 = no pain, 10 = maximal pain). The numeric pain rating 
scale has been found to be a valid and reliable measure of pain 
intensity in adults with arthritis (20). The distance walked in 30 
seconds was measured with a measuring wheel from the start-
ing line to the front of the foot that was in contact with the ground 
at 30 seconds and was farthest from the start. The 30SFW test 
result was the greater distance walked of the two scored trials. 
Participants returned 2‐7 days following the first session and 
performed the 30SFW according to the same procedure and 
with the same examiner as at the first session. A second exam-
iner measured the distance walked in each scored trial at one of 
the two test sessions.
Statistical analysis. The Rand SF‐36 subscale and com-
posite summary scores were calculated with custom formulas in 
an Excel (Microsoft) spreadsheet and are available in an appendix 
to an article by Laucis et al (17). Descriptive statistics were used 
to summarize demographic characteristics, pain measurements, 
KOOS scores, and SF‐36 scores. Qualitative data were reported 
as percentages and numeric counts; quantitative data as means 
± SD or median and interquartile range (IQR). Comparisons 
between groups were performed using Student’s t tests if the data 
were normally distributed based on the Shapiro‐Wilk test or by 
using the Wilcoxon rank‐sum test if otherwise. Intrarater and inter-
rater reliability were assessed using ICC2,1 (21). Measurement error 
was assessed as the standard error of measurement (SEM) and 
calculated as SD × 
√
1− ICC (21). The MDC was calculated at the 
95% confidence level (MDC95) with the formula SEM × 1.96 × 
√
2
. Convergent and discriminant construct validity were examined 
using Pearson’s correlation coefficient and were evaluated using 
the guidelines by Evans (correlation levels: negligible = 0.00‐0.19, 
weak = 0.20‐0.39, moderate = 0.40‐0.59, strong = 0.60‐0.79, 
very strong = 0.80‐1.00) (22).
Convergent validity was assessed by the presence of a 
hypothesized r ≥ 0.60 between the 30SFW test score and scores 
on the KOOS‐ADL, the SF‐36‐PF, and the SF‐36‐PHC (13). Dis-
criminant validity was assessed by the presence of a hypothe-
sized r ≤ 0.39 between the 30SFW score and the score on the 
SF‐36‐MH (13). Known group validity was assessed by compari-
son of the 30SFW scores between groups with Student’s t tests, 
2‐tailed, P < 0.05 (13). All statistical analyses were conducted 
using SAS software v.9.4 (SAS Institute Inc).
Post hoc analysis to calculate gait speed in meters per sec-
ond was performed to enable comparison of study findings to 
previous research.
Table 1. Demographic characteristics of participants
 Descriptor OA (n = 20)
Control  
(n = 20) P Valuea
Age, y    
Mean ± SD 58.30 ± 8.05 57.25 ± 8.71 0.63b
Range 44-72 44-74  
Race    
African American/Black 10 (50.00%) 5 (25.00%)  
Asian 0 (0%) 1 (5.00%)  
Caucasian 10 (50.00%) 14 (70.00%) 0.19c
Average paind    
Median (IQR) 5 (3, 7) 0 (0, 0) <0.0001e
Current paind    
Median (IQR) 4.5 (1, 6) 0 (0, 0) <0.0001e
Abbreviation: IQR, interquartile range; OA, osteoarthritis
aAll P values are two-sided; bP value from two-sample t test; cP value from Fisher’s exact test; 
dNumeric pain rating, 0-10 with 0 = no pain and 10 = maximal pain; eP value from Wilcoxon 
rank-sum test.
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RESULTS
Participant characteristics. Baseline characteristics 
showed no significant difference between knee OA and control 
groups with respect to age or race (P > 0.05) (Table 1). The knee 
OA group had a significantly greater baseline average and cur-
rent pain compared with the control group (P < 0.05) (Table 1). 
The knee OA group showed significantly lower scores in all KOOS 
measures (P < 0.05) (Table 2) and SF‐36 scores except for SF‐36 
Role Function – Emotional and SF‐36‐MH (P = 0.17 and P = 0.49, 
respectively) (Table 3).
Reliability and measurement error. Intrarater (test‐
retest, between sessions) and interrater (within session) reliability 
Table 2. Baseline KOOS subscale scores
 Descriptor OA (n = 20) Control (n = 20) P Valuea,b
KOOS Pain    
Median (IQR) 59.72 (38.89, 72.22) 100 (100, 100) <0.0001
KOOS Symptoms    
Median (IQR) 62.50 (48.21, 73.21) 100 (96.43, 100) <0.0001
KOOS Activity of Daily Living    
Median (IQR) 63.24 (42.65, 88.24) 100 (100, 100) <0.0001
KOOS Sport/Recreation    
Median (IQR) 37.5 (25, 50) 100 (100, 100) <0.0001
KOOS Quality of Life    
Median (IQR) 43.75 (31.25, 62.5) 100 (100, 100) <0.0001
Abbreviation: IQR, interquartile range; KOOS, Knee Injury and Osteoarthritis Outcome Score; 
OA, osteoarthritis.
aAll P values are two-sided; bP value from Wilcoxon rank-sum test.
Table 3. Baseline SF‐36 subscale scores
 Descriptor OA (n = 20) Control (n = 20) P Valuea,b
SF-36 Physical Functioning    
Median (IQR) 55 (35, 80) 100 (97.5, 100) <0.0001
SF-36 Role Function 
- Physical
   
Median (IQR) 62.5 (0, 100) 100 (100, 100) <0.0001
SF-36 Role Function 
- Emotional
   
Median (IQR) 100 (83.33, 100) 100 (100, 100) 0.17
SF-36 Energy    
Median (IQR) 55 (37.5, 65) 80 (65, 85) 0.0009
SF-36 Mental Health    
Median (IQR) 84 (68, 92) 86 (78, 92) 0.49
SF-36 Social Functioning    
Median (IQR) 75 (62.50, 100) 100 (100, 100) 0.003
SF-36 Pain    
Median (IQR) 57.5 (33.75, 78.75) 90 (90, 100) <0.0001
SF-36 General Health    
Median (IQR) 67.5 (60, 77.5) 90 (82.5, 95) 0.0001
SF-36 Physical Health 
Composite
   
Median (IQR) 43.97 (33.11, 52.13) 59.52 (55.86, 61.04) <0.0001
SF-36 Mental Health 
Composite
   
Median (IQR) 49.23 (43.31, 58.56) 57.22 (53.98, 60.52) 0.008
Abbreviation: IQR, interquartile range; OA, osteoarthritis; SF-36 = 36-item Short Form Health 
Survey. aAll P values are two-sided; bP value from Wilcoxon rank-sum test.
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of the 30SFW test was examined with ICC2,1. The results ranged 
from r = 0.95 to r = 0.99 and were found to be excellent. Table 4 
presents ICC2,1 values with 95% confidence intervals, SEM, and 
MDC95 values.
Convergent and discriminant validity. As hypothe-
sized, there were significant strong positive correlations between 
the 30SFW test and the KOOS‐ADL, SF‐36‐PF, and SF‐36‐PHC 
scores (P < 0.05) (Table  5). As hypothesized, the correlation 
between the 30SFW test and the SF‐36‐MH score was nonsignif-
icant and weak (r = 0.32, P = 0.05) (Table 5).
Known groups validity. As hypothesized, the knee OA 
group walked a significantly shorter distance in the 30SFW com-
pared with the control group (P < 0.0001) (Table 6). A very large 
effect size was found between the two groups (Cohen’s d [95% 
CI], session 1: −1.58 [−2.29, −0.87]; session 2: −1.46 [−2.16, 
−0.76]), indicating a large negative effect of knee OA on distance 
walked in the 30SFW (Table  6). Prewalk and postwalk numeric 
pain ratings were significantly higher in the knee OA group than 
in the control group (P < 0.0001). However, the knee OA group 
prewalk to postwalk pain rating change was not significant (P > 
0.05) (Table 6).
Post hoc analysis. Distance walked in the 30SFW at ses-
sion one was divided by 30 seconds to determine gait speed. The 
mean (SD) gait speed for the knee OA group was 1.48 (0.32) m/s 
compared with 1.94 (0.26) m/s for the control group, which were 
significantly different (independent t test, 2‐tailed, P < 0.0001). A 
very large effect size was found between the two groups (Cohen’s 
d [95% CI], −1.58 [−2.29, −0.87]), indicating a large negative 
effect of knee OA on gait speed.
DISCUSSION
This study examined the 30SFW, a novel PPM of walking 
ability, in persons with knee OA compared with an asympto-
matic control group. As hypothesized, the 30SFW had excellent 
interrater and intrarater (test‐retest) reliability for persons with 
knee OA as well as asymptomatic individuals. Our hypotheses 
that the 30SFW as a test of walking performance would demon-
strate excellent convergent, discriminant, and known groups 
construct validity were also supported. In addition, very large 
effect sizes were found for distance walked in the 30SFW and 
for gait speed, indicating that the presence of knee OA had 
a very large effect on distance walked and gait speed in the 
30SFW (23).














Overall 0.99 (0.99, 1.00) 0.29 0.80 0.97 (0.94, 0.99) 1.87 5.17
OA 0.99 (0.99, 1.00) 0.29 0.82 0.96 (0.87, 0.98) 2.05 5.67
Control 0.99 (0.99, 1.00) 0.28 0.79 0.95 (0.89, 0.98) 1.66 4.61
Abbreviation: CI, confidence interval; MDC, minimum detectable change; OA, osteoarthritis; SEM, standard error of measurement.







KOOS-ADL r = 0.70 (0.50, 0.83) <0.0001
SF-36 Physical Functioning r = 0.69 (0.48, 0.82) <0.0001
SF-36 Role Function - Physical r = 0.60 (0.35, 0.77) <0.0001
SF-36 Role Function - Emotional r = 0.37 (0.07, 0.61) 0.02
SF-36 Energy r = 0.55 (0.29, 0.74) 0.0002
SF-36 Mental Health r = 0.32 (0.006, 0.57) 0.05
SF-36 Social Functioning r = 0.51 (0.23, 0.71) 0.0009
SF-36 Pain r = 0.69 (0.48, 0.82) <0.0001
SF-36 General Health r = 0.61 (0.37, 0.77) <0.0001
SF-36 Physical Health Composite r = 0.73 (0.55, 0.85) <0.0001
SF-36 Mental Health Composite r = 0.54 (0.27, 0.73) 0.0004
Abbreviation: KOOS-ADL, Knee Injury and Osteoarthritis Outcome Score – Activity of Daily Living 
subscale; SF-36 = 36-item Short Form Health Survey.
aAll P values are two-sided. 
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Reliability of walking performance of persons with knee OA is 
reported to be better for tests of fast‐paced walking compared with 
usual‐paced walking (24). A systematic review of PPMs for per-
sons with knee and hip OA reported that there is limited evidence 
for reliability and measurement error for PPM of fast‐paced walking 
(10). There was limited evidence for intrarater and interrater reliabil-
ity for a 50‐ft fast‐paced walk test and for a 40‐m fast‐paced walk 
test for mixed populations of hip and knee OA participants who 
were awaiting total joint replacement (10,25,26). Current OARSI 
recommendations for a test of short‐distance walking ability for 
persons with knee and hip OA is the 40‐m fast‐paced walk test, 
based on expert opinion, limited measurement property evidence, 
and feasibility of conducting this walk test (12). More recently, the 
reliability of the 40‐m fast‐paced walk test has been established 
for a mixed population of persons with knee and hip OA as well as 
a population of persons preceding total joint arthroplasty for knee 
OA (11,27). The reliability values for the 30SFW in the current study 
are higher than those reported for the 40‐m fast‐paced walk test 
(intrarater ICC = 0.92‐0.93, interrater ICC = 0.96), yet both studies 
have excellent reliability (11,27). The higher interrater and intrarater 
reliability for the 30SFW may be due to differing test procedures. 
The 40‐m fast‐paced walk test procedure requires frequent start-
ing and stopping of a stopwatch as participants walk beyond end-
points of a 10‐m walkway, turn, and walk back across the walkway 
for a total of four repetitions. This requires an examiner to start or 
stop a stopwatch a total of eight times during the timed test, which 
may be a source of examiner error (28). Additional differing reliabil-
ity results may be due to differing patient populations. The 30SFW 
was tested in a population of persons with symptomatic knee OA 
who were attending physical therapy or who were recruited from 
nonsurgical physician practices or from the community. The 40‐m 
fast‐paced walk test was examined in populations of persons at 
end‐stage OA who were awaiting joint replacement, from a mixed 
population of persons with knee and hip OA, and a population of 
persons with end‐stage knee OA (11,26,27).
To our knowledge, the current study is the first to report con-
struct validity for a PPM of short‐distance walking ability for persons 
with knee OA, reported to be an important construct to measure 
for persons with knee and hip OA (12). In addition to excellent con-
vergent, discriminant, and known groups validity, the 30SFW test 
met 100% of the study hypotheses, demonstrating hypotheses 
testing construct validity. The systematic review of psychometric 
properties of PPM for knee and hip OA did not locate any studies 
with evidence of validity for short‐distance walk tests (10). Gill et al 
Table 6. Pain and distance walked measurements
 Descriptor OA (n = 20)
Control  
(n = 20) P Valuea
Session 1    
Prewalk NPR Median (IQR) 1.5 (0, 5.5) 0 (0, 0) <0.0001b
Postwalk NPR Median (IQR) 1 (0, 4) 0 (0, 0) <0.0001b
Post-Prewalk NPR Change  
Median (IQR)
0 (0, 0) 0 (0, 0) 0.65b
Post-Prewalk NPR Change  
Within-group P value
P = 1.00c … …
Distance (m) mean ± SD 44.37 ± 9.46 58.06 ± 7.80 <0.0001d
Distance effect size – Cohen's d    
 (95% CI)   −1.58 (−2.29, 
−0.87)
Session 2    
Prewalk NPR Median (IQR) 1 (1, 4.5) 0 (0, 0) <0.0001b
Postwalk NPR Median (IQR) 1 (0, 3.5) 0 (0, 0) <0.0001b
Post-Prewalk NPR Change  
Median (IQR)
0 (0, 0) 0 (0, 0) 0.65b
Post-Prewalk NPR Change  
Within-group P value
P = 0.81c   
Distance (m) mean ± SD 45.80 ± 9.88 58.74 ± 7.71 <0.0001d
Distance effect size – Cohen's d    
 (95% CI)   −1.46 (−2.16, 
−0.76)
Abbreviation: CI, confidence interval; IQR, interquartile range; NPR, numeric pain rating; OA, 
osteoarthritis;
aAll P values are two‐sided; bP value from Wilcoxon rank‐sum test (between groups comparison); 
cP value from Wilcoxon signed rank test; dP value from Student’s t test.
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(13) examined the validity of several PPMs and PROMs in persons 
awaiting knee or hip joint replacement for OA. A 50‐foot fast‐paced 
walk test was found to have evidence for convergent validity that 
was due to moderate to high significant correlations with scores on 
the 30‐second chair stand test, the Western Ontario and McMas-
ter Universities Osteoarthritis Index (WOMAC)‐Function subscale, 
SF‐36‐PF, SF‐36‐PHC, and Patient Specific Functional Scale 
(Spearman rho, P < 0.01 for all, ρ = −0.64, ρ = 0.42, ρ = −0.39, ρ = 
−0.38, ρ = −0.36, respectively). In the same study, there was also 
evidence of discriminant validity for the 50‐foot fast‐paced walk test 
that was due to nonsignificant weak association with the SF‐36‐
MH (Spearman rho, ρ = −0.12, P > 0.05) (13). Evidence for known 
groups validity was reported due to significant differences between 
participants who required an assistive gait aid versus those who 
ambulated without an assistive device (independent t test, P < 
0.001) (13). The results of the 30SFW test in the current study were 
similar to those found for the 50‐foot fast‐paced walk test for discri-
minant and known groups validity tests. However, for convergent 
validity testing, the correlations between 30SFW scores and the 
KOOS‐ADL, SF‐36‐PF, and SF‐36‐PHC scores were all stronger 
than the correlations reported for convergent validity for the 50‐foot 
fast‐paced walk test. Interpreting magnitude of correlation is some-
what arbitrary (22), but the correlation levels reported by Gill et al 
(13) for their walk test would have been considered weak for the 
SF‐36‐PF, SF‐36‐PHC, and the Patient Specific Functional Scale 
according to levels proposed by Evans (22). Differing findings for 
convergent validity between our study and the study by Gill et al 
(13) may have been due to different test procedures and different 
patient populations. Participants in the study by Gill et al (13) were a 
mix of females and males (63% female), the average age was older 
than that of our participants (mean = 70.3 years [SD 9.8 years]), it 
contained a mix of persons with knee or hip OA, and the severity 
of OA was likely worse than that of our participants because they 
studied persons awaiting joint replacement surgery. More recently, 
the study by Tolk et al (11) reported that the 40‐m fast‐paced walk 
test did not meet the required level of 75% hypotheses test confir-
mation and thus did not demonstrate construct validity for walking 
ability (4 of 15 [27%] predefined hypotheses achieved) (11). Dif-
ferent findings for validity between the study by Tolk et al (11) and 
the current study may have been due to different test procedures, 
different participant sex (57% female in the earlier study), the older 
age of their participants (mean = 69.3 years [SD 8.2 years]), and 
that their participants were all awaiting joint replacement and thus 
were more likely to have severe knee OA.
Post hoc calculation of gait speed for participants in the 
current study was performed in order to allow comparison with 
previous studies that were anchored on distance. Participants 
in the current study walked faster than those in previous studies 
that examined gait speed for persons with knee or hip OA when 
walking 40 m or 50 ft (11,13,25,26). The difference in gait speed 
between studies may be due to the older average age of partic-
ipants in previous studies, the fact that participants in previous 
studies were awaiting joint replacement so likely had more severe 
OA, the mixed samples of persons with knee and hip OA in previ-
ous studies, and different test procedures.
The 30SFW was found to be a reliable and valid PPM of 
short‐distance walking ability in persons with knee OA. This 
novel PPM is feasible for use in research, in clinical settings, 
and in the community to quantify actual physical function. Min-
imal equipment is required; only a course, a stopwatch or timer, 
a measuring wheel, and tape or cones to mark the course are 
necessary. The course does not need to be an unobstructed 
15‐20 m walkway as required by previous PPMs of short‐dis-
tance walking ability. This is important because smaller clin-
ics, research labs, and community settings may not have this 
length of unobstructed walkway available. The course can be 
rectangular or oblong in shape and should not contain turns 
greater than a 90° angle so that participants do not need to 
slow down when making a turn. The time to conduct the test 
is short, making this feasible for busy clinicians and research-
ers. The time required to perform the 30SFW is the same as 
the time required to perform the 30‐second chair stand test, 
one of the PPMs recommended by OARSI for use with per-
sons with knee or hip OA (12). Using the reported MDC95 for 
distance walked on the 30SFW, clinicians and researchers can 
determine if true change has occurred for a patient or research 
subject, that is, a difference greater than measurement error.
This study has several limitations that must be consid-
ered. The sample size was small and no participants used 
assistive devices. Examiners were not blinded to participant 
group. Although it was not intended to be a study of only 
females, potential knee OA participants who met all study cri-
teria were all female. We did not require diagnostic imaging 
and so are unable to comment on the radiographic degree 
of OA for study participants. Future research should examine 
psychometric properties of the 30SFW in males, those who 
use assistive devices during ambulation, those who have dif-
ferent pathologies, responsiveness, and determination of the 
minimum clinically important difference.
In conclusion, our findings show that the 30SFW is a reli-
able, valid measure of short‐distance walking ability in persons 
with knee OA. It is the first PPM to measure this construct with 
evidence for both reliability and validity. It is feasible for use in 
clinics, research laboratories, and in the community, requiring 
little time, space, or special equipment. Clinicians and research-
ers should consider using the 30SFW to quantify walking ability 
of patients and research subjects as well as to determine if true 
change or difference is present.
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